Blood pressure and risks of vascular complications after percutaneous coronary intervention

Dimensions of Critical Care Nursing

Volumn 26, Issue 3, 2007, Pages 121-127

  Dumont, Cheryl J P ^a,b  

^a Winchester Medical Center   (United States)

^b SHENANDOAH UNIVERSITY   (United States)

Author keywords

Blood pressure; Cardiac catheterization; Percutaneous coronary intervention; Vascular complications

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HIRUDIN DERIVATIVE; HIRULOG; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ARTICLE; CASE CONTROL STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEMOSTASIS; HUMAN; HYPERTENSION; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; NURSE ATTITUDE; NURSING; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; STANDARD; STATISTICAL MODEL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES; VASCULAR DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CASE-CONTROL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HEMOSTASIS, SURGICAL; HEPARIN; HIRUDINS; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NURSE'S ROLE; PEPTIDE FRAGMENTS; PERIOPERATIVE CARE; PRACTICE GUIDELINES; RECOMBINANT PROTEINS; RISK ASSESSMENT; RISK FACTORS; VASCULAR DISEASES; VIRGINIA;

EID: 34247352928     PISSN: 07304625     EISSN: 15388646     Source Type: Journal    
DOI: 10.1097/01.DCC.0000267807.95228.2e     Document Type: Article

References (35)

1. Kohn LT, Corrigan JM, Donaldson MS (eds). To Err is Human. Building a Safer Health System. Washington, DC: National Academy Press; 2000.
2. American Heart Association. Heart Disease and Stroke StatisticsV2006 Update. Dallas, Tex: American Heart Association; 2006.
3. Carere RG, Webb JG, Buller CEH, et al. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J. 2000;139:52-58.
4. Duffin DC, Muhlestein JB, Allison SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13:354-362.
5. Dumont JP, Keeling AW, Bourguignon C, Sarembock IJ, Turner M. Predictors of vascular complications post diagnostic cardiac catheterization and percutaneous coronary interventions. Dimens Crit Care Nurs. 2006;25(3):137-142.
6. Eggebrecht H, Haude M, vonBirgelen C, et al. Early clinical experience with the 6 french AngioSeal device: immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures. Catheter Cardiovasc Interv. 2001;53:437-442.
7. Eidt JF, Habibipour S, Saucedo JF, et al. Surgical complications from hemostatic puncture closure devices. Am J Surg. 1999;178:511-516.
8. Gerckens U, Cattelaens N, Lampe E, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture mediated closure device. Am J Cardiol. 1999;83:1658-1663.
9. Pracyk JB, Wall TC, Longabaugh JP, et al. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol. 1998;81:970-976.
10. Thore V, Berder V, Houplon P, Preiss JP, Selton-Suty C, Juilliere Y. Role of manual compression time and bed rest duration on the occurrence of femoral bleeding complications after sheath retrieval following 4 Fr. left-sided cardiac catheterization. J Interv Cardiol. 2001;14:7-10.
11. Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the AngioSeal closure device following interventional and diagnostic catheterization. Catheter Cardiovasc Interv. 1999;48:162-166.
12. Wiley JM, White CJ, Uretsky FF. Noncoronary complications of coronary intervention. Catheter Cardiovasc Interv. 2002;57:257-265.
13. Anderson K, Bregendahl M, Kaestel H, Skriver M, Ravkilde J. Haematoma after coronary angiography and percutaneous coronary intervention via the femoral artery frequency and risk factors. Eur J Cardiovasc Nurs. 2005;4:123-127.
14. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol. 2000;86:780-782.
15. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38:638-641.
16. Jacksoon JL, Meyer GS, Pettit T. Complications from cardiac catheterization: analysis of a military database. Mil Med. 2000;165:298-301.
17. Kelm M, Perings SM, Jax T, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas. J Am Coll Cardiol. 2002;40:291-297.
18. Mandak JS, Blankenship JC, Gardner LH, et al. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide. J Am Coll Cardiol. 1998;31:1518-1524.
19. Moscucci M, Mansour K, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. Am J Cardiol. 1994;74:448-453.
20. Muller DWM, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 1992;69:63-68.
21. Oweida SW, Roubin GS, Smith RB, Salam AA. Post catheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg. 1990;12:310-315.
22. Sesana M, Vaghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol. 2000;12:395-399.
23. Tavris DR, Gallauresi B, Rich S, Bell C. Relative risks of reported serious injury and death associated with hemostasis devices by gender. Pharmacoepidemiol Drug Saf. 2003;12:237-241.
24. Barkman A, Lunse CP. The effect of early ambulation on patient comfort and delayed bleeding after cardiac angiogram: a pilot study. Heart Lung. 1994;23:112-117.
25. Fowlow B, Price P, Fung T. Ambulation after sheath removal: a comparison of 6 and 8 hours of bed rest after sheath removal in patients following a PTCA procedure. Heart Lung. 1995;24:28-37.
26. Keeling AW, Knight E, Taylor V, Nordt LA. Post cardiac catheterization time-in bed study: enhancing patient comfort through nursing research. Appl Nurs Res. 1994;7:14-17.
27. Keeling AW, Taylor V, Nordt LA, Powers ER. Reducing time in bed after cardiac catheterization (TIBS II). Am J Crit Care. 1996;5:277-281.
28. Keeling AW, Fisher CA, Haugh KH, Powers ER, Turner MS. Reducing time in bed after percutaneous transluminal coronary angioplasty (TIBS III). Am J Crit Care. 2000;9:185-187.
29. Logemann T, Leutmer P, Kaliebe J, Olson K, Murdock DK. Two versus six hours of bed rest following left-sided cardiac catheterization and a meta-analysis of early ambulation trials. Am J Cardiol. 1999;84:486-488.
30. Mah J, Smith H, Jensen L. Evaluation of 3-hour ambulation post cardiac catheterization. Can J Cardiovasc Nurs. 1999;10:23-30.
31. Roebuck A, Jessop S, Turner R, Caplin JL. The safety of two-hour versus four-hour bed rest after elective 6-french femoral cardiac catheterization. Coron Health Care. 2000;4:169-173.
32. Sola R, Pastore GM, Stein B. Early ambulation after diagnostic cardiac catheterization: a 4 french study. J Invasive Cardiol. 2001;13:75-78.
33. Searle MM, Hoff L. Bed rest after elective cardiac catheterization. Prof Nurse. 2000;15:588-591.
34. Vlasic W, Almond D, Massel D. Reducing bed rest following arterial puncture for coronary interventional procedures: impact on vascular complications: the BAC Trial. J Invasive Cardiol. 2001;13:788-792.
35. Waksman R, King SB, Douglas JS, et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol. 1995;75:886-889.